|
Match
|
Document |
Document Title |
|
|
7612198 |
Soluble highly branched glucose polymers
The invention relates to soluble highly branched glucose polymers, having a reducing sugar content of less than 1%, a level of α-1,6 glucoside bonds of between 13 and 17% and an Mw having a value...
|
|
|
7595393 |
Reduced malto-oligosaccharides
Disclosed are a method for the reduction of an oligosaccharide mixture and an oligosaccharide mixture prepared thereby. In accordance with the disclosed invention, a mixture of oligosaccharides...
|
|
|
7582154 |
Compositions of polyol granules and processes of manufacture
The present invention includes methods for preparing polyol products including a method of making a free-flowing granular product comprising: a) charging hydrogenated starch hydrolysate to an...
|
|
|
7569557 |
Compositions of estrogen-cyclodextrin complexes
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
|
|
|
7494761 |
Cyclodextrin derivative, photoresist composition including the cyclodextrin derivative and method of forming a pattern using the photoresist composition
A photoresist film is formed on an object layer of a semiconductor device by coating the object layer with a photoresist composition including about 7 percent to about 14 percent by weight of a...
|
|
|
7473776 |
Soluble hydrogenated starch derivatives containing nondigestible dietary fibres
The invention relates to soluble hydrogenated starch derivatives containing nondigestible dietary fiber, characterized in that they have an ICUMSA coloration value reduced by at least 50%, and a...
|
|
|
7459549 |
Composition for preparing nanoporous material
Disclosed herein is a composition for preparing a nanoporous material. The composition comprises i) a cyclodextrin derivative, ii) a thermostable matrix precursor, and iii) a solvent for dissolving...
|
|
|
7423027 |
Methods of using gamma cyclodextrin to control blood glucose and insulin secretion
Disclosed are methods of producing a blunted postprandial glycemic response in an individual, and/or reducing postprandial insulin secretion, said methods comprising administering to the individual...
|
|
|
7417109 |
Polymers for delivering nitric oxide in vivo
Disclosed are novel polymers derivatized with at least one —NO x group per 1200 atomic mass unit of the polymer. X is one or two. In one embodiment, the polymer is an S-nitrosylated polymer and...
|
|
|
7405293 |
Reduced malto-oligosaccharides
Disclosed are a method for the reduction of an oligosaccharide mixture and an oligosaccharide mixture prepared thereby. In accordance with the disclosed invention, a mixture of oligosaccharides...
|
|
|
7307176 |
Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin
The present invention relates to a method for producing a 2-hydroxypropyl-beta-cyclodextrin inclusion complex of taxol, said 2-hydroxypropyl-beta-cyclodextrin having a degree of substitution of 0.4...
|
|
|
7285157 |
Air filter
An air-filter for a circulating and/or recirculating air system using a filter medium containing a microbiologically effective amount of a polymeric biguanide or salt thereof. Also claimed is a...
|
|
|
7271259 |
Solid phase host compositions
A new family of silicon-based polymers has been prepared in which organic host components are bound covalently. The polymer is a polysilsesquioxane matrix comprising, for example, hosts such as...
|
|
|
7259153 |
Drug formulation and delivery using crystalline methylated cyclodextrins
The present invention is directed to pharmaceutical compositions containing crystalline methylated cyclodextrins, which enhance the solubility of the pharmaceutically active agent or agents of the...
|
|
|
7211662 |
Soluble highly branched glucose polymers and their method of production
The invention relates to soluble highly branched glucose polymers having a reducing sugar content of less than 1%, characterized in that they have a level of α-1,6 glucoside bonds greater than...
|
|
|
7202233 |
Alprazolam inclusion complexes and pharmaceutical compositions thereof
A pharmaceutical composition an inclusion complex and methods for treating patients and preparing said complex disclosed for transmucosal delivery comprising an inclusion complex of (a) alprazolam...
|
|
|
7202231 |
β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided....
|
|
|
7186702 |
Method of treating leishmaniasis using methyl-beta-cyclodextrin
The present invention relates to a composition useful for the treatment of leishmaniasis said composition comprising pharmaceutically effective amount of methyl-beta-cyclodextrin, optionally...
|
|
|
7182941 |
Method for reducing malodor impression on inanimate surfaces comprising uncomplexed cyclodextrin
Methods of treating an inanimate object or inanimate surface which has malodor impression to reduce the malodor impression comprise the step of contacting the inanimate object or inanimate surface...
|
|
|
7166226 |
Ion exchange cryptands covalently bound to substrates
One embodiment of the invention comprises an ion exchange composition formed by reacting unsaturated carbon to carbon moieties pendant from derivatized ion binding cryptands with a support...
|
|
|
7157446 |
Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
A ras-farnesyltransferase inhibitor complex formed from a ras-farnesyltransferase inhibitor or a pharmaceutically acceptable salt thereof, a substituted cyclodextrin, and ethanol is provided. The...
|
|
|
7115586 |
Non-inclusion cyclodextrin complexes
The invention provides a number of methods for enhancing the aqueous solubility of an active ingredient which is insoluble or sparingly soluble in water. In one preferred embodiment, solubilization...
|
|
|
7109324 |
Process for chemically bonding an odor-encapsulating agent to textiles and textiles formed by the process
A process for chemically bonding an odor-encapsulating agent to textiles includes reacting a cyclodextrin with a cross-linking agent capable of forming ether bonds with the cyclodextrin and with...
|
|
|
7105500 |
Process for the antimicrobial treatment of fiber materials
A process for the antimicrobial treatment of fiber materials, comprising applying to the fiber material an inclusion complex of a fiber-reactive cyclodextrin derivative with an antimicrobial agent...
|
|
|
7091335 |
Derivatized reduced malto-oligosaccharides
Disclosed are derivatized malto-oligosaccharides and methods for the preparation thereof. In accordance with the disclosed invention, a malto-oligosaccharide is hydrogenated to thereby obtain a...
|
|
|
7091193 |
Therapeutic formulations
Formulations comprising one or more epothilones together with a pharmaceutically acceptable carrier, in particular such pharmaceutical compositions suitable for oral administration of an epothilone.
|
|
|
7091192 |
Linear cyclodextrin copolymers
Linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers containing an unoxidized and/or an oxidized cyclodextrin moiety integrated into the polymer backbone are described....
|
|
|
7087709 |
Polymers for delivering nitric oxide in vivo
Disclosed are novel polymers derivatized with at least one —NO x group per 1200 atomic mass unit of the polymer. X is one or two. In one embodiment, the polymer is an S-nitrosylated polymer and...
|
|
|
7084132 |
Artemisinins with improved stability and bioavailability for therapeutic drug development and application
A stable form of artemisinin wherein an artelinic acid or artesunic acid is complexed with cyclodextrin analogs, preferably, β-cyclodextrin. The complexed cyclodextrin artemisinin formulation...
|
|
|
7030237 |
Method and equipment for continuous and selective inclusion separation
In a reaction system having at least two liquid-liquid interfaces between an organic phase of raw material containing a compound(s) to be separated and an aqueous phase of an aqueous solution of...
|
|
|
7026008 |
Stable sugar-based hard candy having high index of whiteness
A stable hard-boiled candy prepared with sucrose, hydrogenated starch hydrolysate (HSH) and optionally 42 DE corn syrup. It is a preferred embodiment of the invention that the candy be produced...
|
|
|
7001893 |
Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof
The present invention relates to an inclusion complex of Rifampicin and cyclodextrin (CD) that can be used as an anti-tubercular drug. The present invention also relates to a process for...
|
|
|
6987182 |
Process for producing cold-gelling hydrocolloids
A dry hydrocolloid powder with cold-gel capabilities is produced by: dissolving a hydrocolloid comprising polysaccharide chains in an aqueous solution; heating the dissolved hydrocolloid solution...
|
|
|
6987099 |
Uncomplexed cyclodextrin compositions for odor control
The present invention relates to a stable, aqueous odor-absorbing composition, preferably for use on inanimate surfaces. The composition comprises from about 0.1% to about 20%, by weight of the...
|
|
|
6982256 |
Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
The invention relates to new formulations for improving the local tolerance of intravenously administered 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-b
enzoylguanidine or one of the...
|
|
|
6969706 |
Preserved pharmaceutical compositions comprising cyclodextrins
A composition comprising a cyclodextrin, a guanidine-based cationic compound, and sorbic acid is disclosed herein. Preservatives and methods related thereto, and experimental results suggesting...
|
|
|
6958326 |
Cyclodextrin-drospirenone inclusion complexes
Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability. In specific embodiments the composition...
|
|
|
6949527 |
6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
Disclosed is a 6-mercapto-cyclodextrin derivative having a general formula (I, ) wherein m is 0-7 and n is 1-8 and m+n=7 or 8; R is (C 1-6 ) alkylene, optionally substituted with 1-3 OH groups, or...
|
|
|
6884885 |
Production of cyclodextrin complexes
The process entails increasing the concentration of cyclodextrin to 15% (w/w) and above to form complexes through a precipitation process in order to increase the yield of complexes, increase the...
|
|
|
6884790 |
Verifiable absorption drug delivery form based on cyclodextrins
Solid dosage forms are produced by absorbing solutions of drug:cyclodextrin inclusion complexes on absorbing matrices and then drying. The matrices may, but need not, disintegrate in water. The...
|
|
|
6884789 |
Linear cyclodextrin copolymers
Linear cyclodextrin copolymers and linear oxidized cyclodextrin copolymers containing an unoxidized and/or an oxidized cyclodextrin moiety integrated into the polymer backbone are described....
|
|
|
6878696 |
Process for the stabilization of acylglycerols comprising high amounts of ω-3 polyunsaturated fatty acids by means of γ-cyclodextrin
A method to stabilize acylglycerols comprising ω-3 polyunsaturated fatty acids against oxidative degradation characterized in that γ-cyclodextrin is mixed either batchwise or continuously with...
|
|
|
6861520 |
Process for chemically bonding an odor-encapsulating agent to textiles and textiles formed by the process
A process for chemically bonding an odor-encapsulating agent to textiles includes reacting a cyclodextrin with a cross-linking agent capable of forming ether bonds with the cyclodextrin and with...
|
|
|
6858723 |
Amphiphile cyclodextrins, preparation and use thereof for solubilizing organized systems and incorporating hydrophobic molecules
The invention provides cyclodextrin derivatives that may be used to transport hydrophobic molecules for pharmaceutical or cosmetic applications, by forming organised systems in an aqueous medium,...
|
|
|
6828334 |
Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition
The present invention relates to pharmaceutical compositions containing fenofibrate in the form of an inclusion complex with cyclodextrin, having high dissolution profile and in vivo enhanced...
|
|
|
6825179 |
Active ingredient combinations or adducts of cyclodextrins and quinones
Active ingredient combinations of cyclodextrins and at least one quinone and/or at least one hydroquinone for use in cosmetic or dermatological formulations.
|
|
|
6818662 |
Pharmaceutical composition
The present invention provides a pharmaceutical composition comprising N-(3-chloro-4-morpholin-4-yl)phenyl-N′-hydroxyimidoformami
dine and sulfobutyl ether β-cyclodextrin or a salt thereof,...
|
|
|
6818630 |
Biologically active materials
The present disclosure concerns biologically active materials, particularly materials that comprise a biodegradeable polymer linked to a biologically active agent. The disclosure further concerns...
|
|
|
6780990 |
Hydrogenated starch hydrolysate
A hydrogenated starch hydrolysate having the following saccharide contents (based on the solids content of the hydrogenated starch hydrolysate): A.<8 wt.-% of hydrogenated monosaccharides...
|
|
|
6737414 |
Composition for enteral nutrition comprising fibres
The subject of the invention is a fiber-enriched composition for enteral nutrition, characterized in that it comprises 0.5 to 20%, preferably 1 to 10%, and still more preferably 1 to 5% by dry...
|